From his perspective, one of the most persistent misconceptions in prostate cancer care relates to how patients interpret ...

Becker’s ASC Review sat down with Randy Whaley, director of business development for United Medical Systems, to tackle a reader’s question about what is needed for an ASC to be able to offer and ...

An implantable microdevice safely delivered multiple drugs directly into prostate cancer lesions, enabling assessment of tumor-specific responses. All 14 patients successfully underwent robot-assisted ...

In data supporting FDA approval, 48.1% implanted with Prodeon’s Urocross saw International Prostate Symptom Score ...

For prostate and penile cancer, scientists have developed an implant the size of a grain of rice that can deliver targeted radiation to the problem area and nowhere else. Share on Facebook (opens in a ...

Comparative real-world survival and prescription patterns of darolutamide versus apalutamide in non-metastatic hormone-resistant prostate cancer. This is an ASCO Meeting Abstract from the 2026 ASCO ...

While prostate cancer affects one in eight men, early detection and advanced treatment options mean patients are living longer, healthier lives after diagnosis, according to the American Cancer ...

The NICE IPG means that UK urologists will be able to routinely offer the novel UroLift system to their patients for the first time outside of a clinical trial. The implants are used to treat BPH – a ...

A 76-year-old man underwent retropubic prostatectomy for obstructive symptoms 10 years ago. He now presents with newly diagnosed prostate carcinoma, Gleason score 4 (2+2), PSA 8.2, stage T1c, prostate ...

Study flowchart of patient selection: Inclusion and exclusion criteria. ED, erectile dysfunction; EDITS, Erectile Dysfunction Inventory of Treatment Satisfaction; RCP, radical cystoprostatectomy; RP, ...